相关实验视频

Updated: Jul 6, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

合成一些新的1,3,4-氧化衍生物,并评估它们的抗癌活性

Leyla Yurttaş¹, Asaf Evrim Evren^1,2, Aslıhan Kubilay¹

¹Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, 26470 Eskişehir, Turkey.

|January 1, 2024

概括

新的抗癌药物被合成和测试. 化合物4h对A549肺癌细胞表现出很好的抗癌活性,诱导了细胞亡并抑制了MMP-9,这表明了潜在的治疗应用.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
癌症研究癌症研究

背景情况:

新型抗癌药物的开发对于改善癌症治疗结果至关重要.
奥克萨迪亚醇衍生物已经被证明是潜在的化疗剂.

研究的目的:

合成和评估新的2-[(5-((2-乙胺基) 甲基) -1,3,4-氧化-2-yl) thio]乙胺衍生物的抗癌活性.
为了研究最强效化合物的作用机制.

主要方法:

合成12种新型氧沙衍生物 (4a-4l化合物).
在体外对A549 (肺癌),C6 (质瘤) 和L929 (纤维细胞) 细胞系进行抗癌查.
诱导亡,细胞周期分析和线粒体膜潜能测试.
矩阵金属蛋白酶-9 (MMP-9) 抑制试验.
在体物理化学性质预测和分子对接研究.

主要成果:

化合物4f,4i,4k和4l对A549细胞具有显著的细胞毒性 (IC50:1.59-7.48μM).
化合物4h对A549细胞 (IC50:<0.14 μM) 和C6细胞 (IC50:13.04 μM) 具有强大的抗癌活性.
最活跃的化合物诱导了亡,在G0/G1阶段停止了细胞周期,并抑制了MMP-9.
化合物4h显示出强烈的MMP-9抑制 (IC50: 1.65μM) 和有利的in silico特性.

结论:

合成的oxadiazole衍生物具有显著的抗癌潜力,特别是化合物4h.
化合物4h的机制涉及亡诱导,细胞循环停止和MMP-9抑制.
这些发现凸显了这些新型化合物在癌症治疗中的治疗潜力.

更多相关视频

Facile Preparation of 4-Substituted Quinazoline Derivatives

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

Solid-phase Synthesis of [4.4] Spirocyclic Oximes

Solid-phase Synthesis of [4.4] Spirocyclic Oximes

Published on: February 6, 2019

相关概念视频

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...